Standard Biotools
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $44,969 | $37,205 | $45,540 | $28,188 |
Gross Profit | 23,261 | 14,908 | 24,188 | 13,357 |
EBITDA | -31,718 | -38,132 | -33,540 | -11,000 |
EBIT | -35,149 | -41,988 | -38,734 | -14,906 |
Net Income | -26,938 | -45,718 | -32,156 | -19,776 |
Net Change In Cash | 44,969 | 37,205 | 45,540 | 28,188 |
Free Cash Flow | -30,124 | -40,987 | -63,257 | -14,139 |
Cash | 210,647 | 269,811 | 287,057 | 51,704 |
Basic Shares | 371,538 | 372,331 | 294,125 | 79,729 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $106,340 | $97,948 | $130,581 | $138,144 |
Gross Profit | 50,450 | 37,051 | 77,266 | 83,326 |
EBITDA | -47,859 | -113,489 | -44,257 | -34,605 |
EBIT | -63,039 | -128,516 | -67,459 | -52,546 |
Net Income | -74,656 | -190,098 | -59,237 | -53,020 |
Net Change In Cash | 106,340 | 97,948 | 130,581 | 138,144 |
Cost of Revenue | 53,261 | |||
Free Cash Flow | -46,118 | -93,195 | -57,325 | -28,134 |
Cash | 51,704 | 81,309 | 28,451 | 68,520 |
Basic Shares | 79,160 | 78,305 | 75,786 | 72,044 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.07 |
2024-06-30 | -$0.12 |
2024-03-31 | -$0.27 |
2023-12-31 | -$0.25 |
